About us
Making a difference
Waisenmedizin e.V. is a non-profit organisation dedicated to improving the health of patients with diseases neglected by industrial research and development worldwide. We are a registered charity based in Germany (VR 3387) and are eligible to receive tax-deductible donations. Founded in 2000, our mission is to advance human rights, global health, and scientific progress, on the basis of the Social Charter of the Council of Europe.
Our impact: A global network
Waisenmedizin e.V. is based in Europe, with our headquarters located in Freiburg im Breisgau, Germany. Our team extends across Austria, Germany, and Switzerland. To amplify our global reach and share our impact, we have been awarded a Google for Nonprofits account.
Advancing treatment for neglected tropical diseases
Waisenmedizin e.V. has been at the forefront of combating skin-related neglected tropical diseases, particularly Old World cutaneous leishmaniasis, since its inception. Our research has been widely recognised through publications in scientific journals and presentations at renowned international conferences, including the ICPIC, DNDi, Institut Pasteur, and WHO. Our contributions have also been instrumental in five doctoral research theses in collaboration with the University of Freiburg, University of Erlangen, University of Magdeburg, the University of Heidelberg, and the University of Greifswald.
Waisenmedizin e.V. is actively involved in the global health community, serving as an observing member of the NNN, a member of the FAF, and a former member of the Kangaroo Group.
A significant milestone in our journey has been the receipt of special authorization from the BfArm for our wound dressing, LeiProtect®. This innovative medical device is designed to address cutaneous leishmaniasis and offers hope for improved treatment outcomes for patients in Germany and beyond.
Expanding our opportunities: Future plans
Waisenmedizin e.V. is committed to expanding its global impact. Our future endeavours will focus on:
Participating in the conference of international non-governmental organisations at the Council of Europe to share our experiences in human rights and health in leishmaniasis-endemic regions.
Raising awareness among healthcare providers in endemic countries about the importance of aseptic wound care for cutaneous leishmaniasis patients, emphasising the benefits of our LeiProtect® wound dressing.
Conducting further research and development of LeiProtect® in both Germany and endemic countries to enhance its efficacy and accessibility.